A collection of news and information related to National Institute of Arthritis and Musculoskeletal and Skin Diseases published by this site and its partners.
Displaying items 1-3 of 3 » View wsbt.com items only
On a recent ski trip, my best friend handed me a flask of cinnamon schnapps. He called it "courage in 100-proof form," and I needed it. I was perched at the edge of a cliff, looking at a 20-foot drop into thigh-deep powder. Nearly a decade ago, when I...
Hartford CourantIt can happen while you're hauling boxes to the attic, gardening in the yard or even sitting in front of a computer too long. Back pain: It's one of the most common medical problems in the United States, according to the National Institutes of Health....
Special to the Los Angeles TimesThe U.S. Food and Drug Administration recently approved a new drug for osteoporosis. Amgen's Prolia (denosumab) prevents fractures in postmenopausal women at a rate similar to the most popular drugs on the market — bisphosphonates such as Fosamax,...
Tags: Fosamax (drug), Health, Post Menopause, Amgen Inc., Mayo Clinic
Feb 27, 2012 |Story| Los Angeles Times
Jun 21, 2010 |Story| Hartford Courant
Jul 6, 2010 |Story| Los Angeles Times
Original site for National Institute of Arthritis and Musculoskeletal and Skin Diseases topic gallery.